Search research articles
Contact Us
Filters
Showing results (181-190 of 222) with videos related to
Page
of 23
Sort By:
Molecular Pharmacology
|
December 4, 2014
A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo
Aida Oliván-Viguera, Marta Sofía Valero, Nicole Coleman, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells
Dilpreet Kour, Christine A Bowen, Upasna Srivastava, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Kv1.3 inhibition alleviates neuropathology via neuroinflammatory and resilience pathways in a mouse model of Aβ pathology
Rashmi Kumari, Christine Bowen, Upasna Srivastava, et al.
British Journal of Cancer
|
November 22, 2017
The combined activation of K<sub>Ca</sub>3.1 and inhibition of K<sub>v</sub>11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
Serena Pillozzi, Massimo D'Amico, Gianluca Bartoli, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
August 27, 2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Victor Chi, Michael W Pennington, Raymond S Norton, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 24, 2025
Identification of Novel Kv1.3 Channel-Interacting Proteins Using Proximity Labelling in T-Cells
Dilpreet Kour, Christine A Bowen, Upasna Srivastava, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels
Ivica Grgic, Eva Kiss, Brajesh P Kaistha, et al.
Journal of Neurochemistry
|
February 28, 2025
Microglia-Mediated Synaptic Dysfunction Contributes to Chemotherapy-Related Cognitive Impairment
Jingxiong Wang, Hua Zhang, Marc Augenreich, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 27, 2014
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant
Nichole Coleman, Hai M Nguyen, Zhengyu Cao, et al.
Bioelectricity
|
September 2, 2021
Extracellular K<sup>+</sup> Dampens T Cell Functions: Implications for Immune Suppression in the Tumor Microenvironment
Seow Theng Ong, Aik Seng Ng, Xuan Rui Ng, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 222) with videos related to
Sort By:
Page
of 23
Molecular Pharmacology
|
December 4, 2014
A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo
Aida Oliván-Viguera, Marta Sofía Valero, Nicole Coleman, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells
Dilpreet Kour, Christine A Bowen, Upasna Srivastava, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Kv1.3 inhibition alleviates neuropathology via neuroinflammatory and resilience pathways in a mouse model of Aβ pathology
Rashmi Kumari, Christine Bowen, Upasna Srivastava, et al.
British Journal of Cancer
|
November 22, 2017
The combined activation of K<sub>Ca</sub>3.1 and inhibition of K<sub>v</sub>11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
Serena Pillozzi, Massimo D'Amico, Gianluca Bartoli, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
August 27, 2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Victor Chi, Michael W Pennington, Raymond S Norton, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
November 24, 2025
Identification of Novel Kv1.3 Channel-Interacting Proteins Using Proximity Labelling in T-Cells
Dilpreet Kour, Christine A Bowen, Upasna Srivastava, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels
Ivica Grgic, Eva Kiss, Brajesh P Kaistha, et al.
Journal of Neurochemistry
|
February 28, 2025
Microglia-Mediated Synaptic Dysfunction Contributes to Chemotherapy-Related Cognitive Impairment
Jingxiong Wang, Hua Zhang, Marc Augenreich, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 27, 2014
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant
Nichole Coleman, Hai M Nguyen, Zhengyu Cao, et al.
Bioelectricity
|
September 2, 2021
Extracellular K<sup>+</sup> Dampens T Cell Functions: Implications for Immune Suppression in the Tumor Microenvironment
Seow Theng Ong, Aik Seng Ng, Xuan Rui Ng, et al.
Page
of 23